Amikin Related Published Studies
Well-designed clinical trials related to Amikin (Amikacin)
Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity. [2011.08]
Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. [2011.07.01]
Population pharmacokinetics of amikacin in a Korean clinical population. [2011.06]
Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia. [2011.05]
The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis. [2011.02]
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital. [2010.08]
Impact of infusion method on amikacin serum levels in humans. [2010.08]
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial. [2010.04]
Effect of topical application of 1% diclofenac sodium liposomal cream on inflammation in healthy horses undergoing intravenous regional limb perfusion with amikacin sulfate. [2009.11]
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia. [2009.09]
Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison. [2009.04]
A comparative study to assess the effect of amikacin sulfate bladder wash on catheter-associated urinary tract infection in neurosurgical patients. [2009.01]
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. [2008.06]
Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients. [2008.05]
An evaluation of amikacin nephrotoxicity in the hematology/oncology population. [2008.03]
[Dynamic changes of blister fluid amikacin concentration after its early-stage administration in severely burned patients] [2007.10]
Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. [2007.03]
Efficacy and renal toxicity of one daily dose of amikacin versus conventional dosage regime. [2007.02]
Effect of intrathecal amikacin administration and repeated centesis on digital flexor tendon sheath synovial fluid in horses. [2007.01]
Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics. [2005.11.21]
Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II. [2005.11]
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia. [2005.06]
Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia. [2004.07.15]
Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life. [2004]
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy. [2003.12]
Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers. [2003.07]
Ticarcillin-clavulanic acid plus amikacin versus ceftazidime plus amikacin in the empirical treatment of fever in acute leukemia: a prospective randomized trial. [2003.06]
Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma. [2003.04]
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial. [2002.07]
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients. [2002.01]
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia. [2001.10.15]
Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies. [2001.10]
Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients. [2001.09]
Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey. [2001.06]
The early bactericidal activity of amikacin in pulmonary tuberculosis. [2001.06]
Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors. [2001.04]
Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial. [2001.03]
Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer. [2001.02]
Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study. [2001]
Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever. [2000.12]
Isepamicin versus amikacin for the treatment of acute pyelonephritis in children. [2000.02]
Pharmacokinetic changes of theophylline and amikacin through the menstrual cycle in healthy women. [1999.12]
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of Turkey. [1999.09]
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients. [1999.07]
Once versus twice daily amikacin in neonates: prospective study on toxicity. [1999.06]
[Phare study. Comparative study of combined cefepime-amikacin versus ceftazidime combined with amikacin in the treatment of nosocomial pneumonias in ventilated patients. Multicenter group study] [1999.02]
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team. [1998.12.24]
[Comparative study of meropenem and amikacin/metronidazole combination in the treatment of severe abdominal surgical infections] [1998.11.08]
Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections. [1998.10]
Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients. [1998.07]
Well-designed clinical trials possibly related to Amikin (Amikacin)
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa
infection. [2013]
Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations. [2010.12]
Is perioperative intravesically applied antibiotic solution effective in the prophylaxis of urinary tract infections after renal transplantation? [2010.07]
Is perioperative intravesically applied antibiotic solution effective in the prophylaxis of urinary tract infections after renal transplantation? [2010]
Evaluation of indwelling intravenous catheters for the regional perfusion of the limbs of horses. [2009.10.24]
[Current status of the management of pediatric infective endocarditis: a national survey] [2009.08]
[Comparison between two antibiotic schemes in relation to surgical site infection in children: a randomized clinical trial] [2009.07]
Aerosolized antibiotics to treat ventilator-associated pneumonia. [2009.04]
Evaluation of polysulfated glycosaminoglycan or sodium hyaluronan administered intra-articularly for treatment of horses with experimentally induced osteoarthritis. [2009.02]
Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India. [2008.06]
Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting. [2008.03]
Comparison of two indirect techniques for local delivery of a high dose of an antimicrobial in the distal portion of forelimbs of horses. [2008.03]
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study. [2007.11]
Impact of ibuprofen administration on renal drug clearance in the first weeks of life. [2006.10]
Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial. [2006.02]
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. [2006.02]
Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen. [2005.08]
Management of diabetic foot in a Jordanian hospital. [2005.05]
Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. [2004.06.01]
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. [2003.09.01]
Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina. [2003.04.01]
Comparison of 2 techniques for regional antibiotic delivery to the equine forelimb: intraosseous perfusion vs. intravenous perfusion. [2001.08]
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. [2001.04.15]
[Combination therapy of antibiotics and intravenous immunoglobulin] [2001.04]
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study. [2001.03]
Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia. [2001.02]
[Efficacy of monotherapy by meropenem in ventilator-associated pneumonia] [2001]
Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. [2000.08]
Oral administration of cefixime to lower risk febrile neutropenic children with cancer. [2000.06.15]
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. [1999.07.29]
Once daily isepamicin treatment in complicated urinary tract infections. [1999.06]
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients. [1999.03]
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial. [1999.01.01]
Percutaneous suprapubic transvesical route: a new and comfortable method of intraprostatic injection. [1998.08]
[Bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis] [1997.12]
Other research related to Amikin (Amikacin)
Administration of higher doses of amikacin in early stages of sepsis in
critically ill patients. [2014]
Randomized comparison of piperacillin-tazobactam plus amikacin versus
cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in
children with lymphoma and solid tumors. [2013]
Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia
after transrectal ultrasound guided biopsy of the prostate. [2013]
BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia. [2011.12.07]
Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study. [2011.10.31]
Is ceftizoxime an appropriate surrogate for amikacin in neonatal sepsis treatment? A randomized clinical trial. [2011.08]
A double-blind study of the efficacy and safety of multiple daily doses of amikacin versus one daily dose for children with perforated appendicitis in Costa Rica. [2011.08]
Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study. [2011.07]
Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy. [2011.06]
Comparison of two tourniquets and determination of amikacin sulfate concentrations after metacarpophalangeal joint lavage performed simultaneously with intravenous regional limb perfusion in horses. [2011.05]
Successful treatment of Nocardia actinomycetoma with meropenem and amikacin combination therapy. [2011.04]
Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates. [2011.03]
Pharmacokinetics of amikacin in plasma and selected body fluids of healthy horses after a single intravenous dose. [2011.01]
Is ceftizoxime an appropriate surrogate for amikacin in neonatal sepsis
treatment? A randomized clinical trial. [2011]
Effects of clinical decision support on initial dosing and monitoring of
tobramycin and amikacin. [2011]
Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles. [2010.12.16]
|
